UNSPSC 41141956: Estradiol test system

In this classification, Estradiol test system connotes a device used to measure Estradiol levels. US FDA regulates Estradiol test system under 21 CFR 862.1260 and under FDA product code CHP.

UNSPSC 41141956 Estradiol test system (Commodity) encompasses diagnostic and forensic laboratory reagents, testing equipment, and certified reference standards used by state and local public health, criminal justice, and forensic agencies for substance analysis, disease screening, and method validation. Recent state and local solicitations reveal that the code captures a broader range of laboratory consumables and equipment than the nominal "estradiol test system" designation suggests: state and local governments are actively procuring immunoanalysis Direct ELISA kits for drug screening, certified drug reference standards for forensic validation, mosquito-borne illness test kits, and DNA screening kits for forensic and public health applications. Issuing bodies include state departments of public safety, health and human services, criminal justice, financial and professional regulation, county forensic laboratories, and specialized state laboratory systems. The work involves competitive and sole-source procurements, with responses typically due within two to four weeks of posting and contract terms ranging from one year with optional extensions to shorter periods tied to federal grant cycles.

Activity concentrates in Texas and Florida, with secondary presence in Illinois. The Texas Department of Public Safety posted an IFB due July 23, 2026, for 12 line items of Direct ELISA immunoanalysis reagent kits (cannabinoids, opiates, benzodiazepines, and other controlled substances) for the Crime Lab Division in Austin. Pinellas County, Florida, issued an ITQ due April 23, 2026, for 131 line items of certified drug reference standards (purity ≥97%, ISO 17025 and 17034 accredited) totaling $49,034 in Paul Coverdell forensic improvement grant funding, with five percent price preference for Certified Small Business Enterprises. The Texas Health and Human Services Commission solicited QIAxcel and QIAamp DNA screening kits (IFB HHS0016902v2) with bids due January 29, 2026, against a historical spend range of $25,050 to $30,000 for Fiscal Year 2025. The Illinois Department of Financial and Professional Regulation established a joint purchase master contract for RAMP mosquito-borne illness test kits through sole source award to ADAPCO, LLC. All recent opportunities require firm pricing, detailed vendor credentials, and compliance with state financial documentation or HUB subcontracting plan requirements where applicable.